Latest National Cancer Programme bulletin published

The March edition of the National Cancer Programme bulletin has been issued.  The bulletin provides information about various cancer-related policy developments and implementation news for the National Cancer Programme.

The latest bulletin draws attention to:

  • be clear on cancer campaign towards achieving earlier diagnosis of cancer in order to improve cancer survival rates
  • national campaign to promote awareness and earlier diagnosis of lung cancer
  • announcement on palliative care funding pilot sites

The latest editions of the National Cancer Programme bulletin can now be found here.

For previous editions of the bulletin prior to September 2011 visit here.

The next edition of the bulletin will be published at the end of May 2012.

Page published: Tue 10 April 2012

It is supported by 8 companies:

  • Amgen
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Lilly
  • Novartis
  • Pfizer
  • Roche